|
GMCL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.51810000523523E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.24950108224698E-11 |
| Normal-vs-Stage2 |
1.115860E-02 |
| Normal-vs-Stage3 |
2.432800E-01 |
| Normal-vs-Stage4 |
7.553400E-01 |
| Stage1-vs-Stage2 |
1.787430E-01 |
| Stage1-vs-Stage3 |
5.983000E-03 |
| Stage1-vs-Stage4 |
1.476650E-01 |
| Stage2-vs-Stage3 |
3.876800E-01 |
| Stage2-vs-Stage4 |
2.927000E-01 |
| Stage3-vs-Stage4 |
4.919800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.07899999730088E-08 |
| Normal-vs-AfricanAmerican |
1.027630E-04 |
| Normal-vs-Asian |
2.633800E-01 |
| Caucasian-vs-AfricanAmerican |
8.594400E-01 |
| Caucasian-vs-Asian |
8.279000E-01 |
| AfricanAmerican-vs-Asian |
8.682000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.24540394558426E-11 |
| Normal-vs-Female |
5.237800E-01 |
| Male-vs-Female |
6.03539999999292E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.434090E-02 |
| Normal-vs-Extreme_Weight |
3.60045326885938E-12 |
| Normal-vs-Obese |
3.240900E-03 |
| Normal-vs-Extreme_Obese |
8.374400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.466400E-02 |
| Normal_Weight-vs-Obese |
6.803600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.678000E-01 |
| Extreme_Weight-vs-Obese |
1.378980E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.222800E-01 |
| Obese-vs-Extreme_Obese |
6.040400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.732590E-01 |
| Normal-vs-Age(41-60Yrs) |
7.777200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.58500002012119E-09 |
| Normal-vs-Age(81-100Yrs) |
7.45870000207205E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.193600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.596030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.916400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.997600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.460000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.690360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.00925992194834E-12 |
| Normal-VS-Type2 PRCC |
2.995500E-03 |
| Normal-VS-KIRP CIMP |
1.738180E-01 |
| Normal-VS-Unclassified PRCC |
1.123370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.702900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.553930E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.335700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.076400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.812200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.780230E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55625999999076E-05 |
| Normal-vs-N1 |
8.755400E-01 |
| Normal-vs-N2 |
4.767200E-01 |
| N0-vs-N1 |
4.683000E-03 |
| N0-vs-N2 |
2.663600E-01 |
| N1-vs-N2 |
5.005000E-01 |
|
|
